Table 3 Socio-demographic and clinical characteristics
Age, years (mean ± SD) | 42.3 ± 6.6 |
Gender - Male, % (n) | 78.0 (393) |
Educational level, % (n) | |
4 years or less | 13.7 (69) |
5–9 years | 62.2 (314) |
10 years or more | 24.1 (121) |
Marital status, % (n) | |
Single | 54.8 (276) |
Married | 23.8 (120) |
Divorced | 20.2 (102) |
Widow | 1.2 (6) |
Professional status, % (n) | |
Student | 2.0 (10) |
Unemployed | 61.5 (310) |
Employed | 28.8 (145) |
Retired | 6.0 (30) |
Other | 1.8 (9) |
Substance abuse (current), % (n)a | |
Intravenous drug use | 3.6 (18) |
Non-intravenous drug use | 8.1 (41) |
Alcohol abuse | 9.1 (46) |
Opioid substitution treatment | 83.5 (421) |
Other | 9.9 (50) |
HCV Transmission Mode, % (n)a | |
Intravenous drug use | 65.7 (331) |
Post-transfusion | 1.0 (5) |
Peri-natal | 0.0 (0) |
Sexual | 10.5 (53) |
Other | 2.4 (12) |
Unknown | 20.6 (104) |
Time since HCV diagnosis, years (mean ± SD), n = 356 | 11.0 ± 6.0 |
HCV Genotype, % (n), n = 502 | |
1 | 2.4 (12) |
1a | 0.8 (4) |
1b | 0.4 (2) |
2 | 1.2 (6) |
3 | 1.6 (8) |
4 | 1.0 (5) |
Unknown | 92.6 (465) |
HCV viral load, RNA, x106 IU/mL (mean ± SD), n = 27 | 0.5 ± 1.5 |
Comorbidities, % (n)a | |
HIV | 25.8 (130) |
Hepatitis B | 12.5 (63) |
Mental disorders | 16.1 (81) |
Other | 7.5 (38) |
Past referrals to HCV treatment, % (n) | 68.3 (344) |
Past HCV treatment, % (n) | 21.0 (106) |
Number visits to the SDTC in the last six months (mean ± SD) | 7.6 ± 7.5 |
Number visits to a liver specialist in the last six months (mean ± SD) | 1.7 ± 2.3 |